Literature DB >> 23544964

Cognitive change in newly-diagnosed patients with Parkinson's disease: a 5-year follow-up study.

Mark Broeders1, Daan C Velseboer, Rob de Bie, Johannes D Speelman, Dino Muslimovic, Bart Post, Rob de Haan, Ben Schmand.   

Abstract

Cognitive change is frequently observed in patients with Parkinson's disease (PD). However, the exact profile and extent of cognitive impairments remain unclear due to the clinical heterogeneity of PD and methodological issues in many previous studies. In this study, we aimed to examine the severity, frequency, and profile of cognitive changes in newly diagnosed PD patients over 5 years. At baseline and after 3 and 5 years, a hospital-based sample of PD patients (n = 59) and healthy controls (n = 40) were given neuropsychological tests covering six cognitive domains. Patients showed greater decline over time than healthy controls on all cognitive domains, except for attention. The profile of decline showed that psychomotor speed and memory were most affected. At the individual level 53% of the patients showed more cognitive decline than controls. Age at onset and memory impairment at baseline predicted cognitive decline. Cognitive functions in PD patients show greater decline in most domains than in healthy elderly over the course of 5 years. Due to selection bias as a result of attrition, the actual degree of decline may be greater than reported here.

Entities:  

Mesh:

Year:  2013        PMID: 23544964     DOI: 10.1017/S1355617713000295

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  27 in total

Review 1.  Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.

Authors:  Katherine Leaver; Kathleen L Poston
Journal:  Neuropsychol Rev       Date:  2015-12-01       Impact factor: 7.444

2.  Sensitive measures of executive dysfunction in non-demented Parkinson's disease.

Authors:  Nicholas T Bott; Erica T Johnson; Norbert Schuff; Nicholas Galifianakis; Trishna Subas; Jessica Pollock; Peter Pressman; Joel H Kramer; Katherine L Possin
Journal:  Parkinsonism Relat Disord       Date:  2014-10-15       Impact factor: 4.891

3.  Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.

Authors:  Jenny Ceccarini; Cindy Casteels; Rawaha Ahmad; Melissa Crabbé; Laura Van de Vliet; Heleen Vanhaute; Mathieu Vandenbulcke; Wim Vandenberghe; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-24       Impact factor: 9.236

Review 4.  The spectrum of cognitive impairment in Lewy body diseases.

Authors:  Jennifer G Goldman; Caroline Williams-Gray; Roger A Barker; John E Duda; James E Galvin
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 5.  Neuropsychiatric Issues in Parkinson's Disease.

Authors:  Jeffrey W Cooney; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

Review 6.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

7.  Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.

Authors:  Rui Liu; David M Umbach; Alexander I Tröster; Xuemei Huang; Honglei Chen
Journal:  Parkinsonism Relat Disord       Date:  2020-02-11       Impact factor: 4.891

8.  Longitudinal study of normal cognition in Parkinson disease.

Authors:  Kara Pigott; Jacqueline Rick; Sharon X Xie; Howard Hurtig; Alice Chen-Plotkin; John E Duda; James F Morley; Lama M Chahine; Nabila Dahodwala; Rizwan S Akhtar; Andrew Siderowf; John Q Trojanowski; Daniel Weintraub
Journal:  Neurology       Date:  2015-09-11       Impact factor: 9.910

9.  Cognitive and motor deficits in older adults with HIV infection: Comparison with normal ageing and Parkinson's disease.

Authors:  Eva M Müller-Oehring; Rosemary Fama; Taylor F Levine; Cheshire Hardcastle; Ryan Goodcase; Talora Martin; Varsha Prabhakar; Helen M Brontë-Stewart; Kathleen L Poston; Edith V Sullivan; Tilman Schulte
Journal:  J Neuropsychol       Date:  2020-10-08       Impact factor: 2.864

Review 10.  Parkinson's disease mild cognitive impairment: application and validation of the criteria.

Authors:  Gert J Geurtsen; Jeroen Hoogland; Jennifer G Goldman; Ben A Schmand; Alexander I Tröster; David J Burn; Irene Litvan
Journal:  J Parkinsons Dis       Date:  2014       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.